Chondrosarcoma: With Updates on Molecular Genetics

Table 2

Summary of frequency, age, sex, and prognosis of CHSs.

Subtype	Frequency	Gender (M : F)	Peak age	5-year survival
Conventional	85%	1.5–2 : 1	40–60	G1:89%, G2, and G3:57%
Periosteal	<2%	Slight male predilection	20–30	83%
Dedifferentiated	10%	1 : 1	50–60	<10%
Mesenchymal	<2–13%	1 : 1	10–20	54.6%
Clear cell	1-2%	2.6 : 1	20–30	>80%